Dasatinib enhances the expansion of CD56+CD3- NK cells from cord blood.
Junji
J
Tanaka
Junichi
J
Sugita
Souichi
S
Shiratori
Akio
A
Shigematsu
Masahiro
M
Imamura
D017252:CD3 Complex / Q000378:metabolism; D019002:CD56 Antigen / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D000069439:Dasatinib; D004353:Drug Evaluation, Preclinical; D005312:Fetal Blood / Q000166:cytology* / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology*; D020825:T-Box Domain Proteins / Q000235:genetics / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects; D000098815:T-bet Transcription Factor
D017252:CD3 Complex; D019002:CD56 Antigen; C491199:EOMES protein, human; C522918:NCAM1 protein, human; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D020825:T-Box Domain Proteins; D000098815:T-bet Transcription Factor; D013844:Thiazoles; D000069439:Dasatinib